Cases & Deals

  • Home
  • Practices
  • Sanofi defends proposed class action alleging conspiracy to raise prices

Share

Sanofi defends proposed class action alleging conspiracy to raise prices

September 2017

Client(s) Sanofi-Aventis U.S. LLC

Jones Day is defending Sanofi-Aventis U.S. LLC against a proposed class action alleging that the company conspired with or through pharmacy benefit managers to raise prices for its diabetes drug, Lantus, in violation of federal and state antitrust, consumer protection, fraud, RICO, and employee benefit laws.

Chaires v. Novo Nordisk Inc., No. 17-cv-00699 (D.N.J.)

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.